Evidence map›Paper›PMID 28255762›Full record

ArticleMolecular genetics and genomics : MGG2017

Semax, an analog of ACTH

Ekaterina V Medvedeva, Veronika G Dmitrieva, Svetlana A Limborska, Nikolay F Myasoedov, Lyudmila V Dergunova

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular genetics and genomics : MGG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Effect of Oligopeptides-Homologues of the Fragment of ACTHTurkish journal of pharmaceutical sciences · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Brain Protein Expression Profile Confirms the Protective Effect of the ACTHInternational journal of molecular sciences · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ekaterina V MedvedevaInstitute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia. medvedevaekaterina@yandex.ru.
Veronika G DmitrievaInstitute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia.
Svetlana A LimborskaInstitute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia.
Nikolay F MyasoedovInstitute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia.
Lyudmila V DergunovaInstitute of Molecular Genetics, Russian Academy of Sciences, Moscow, 123182, Russia.
Institute of Molecular Genetics · RUMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain stroke continues to claim the lives of million people every year. To build the effective strategies for stroke treatment it is necessary to understand the neuroprotective mechanisms that are able to prevent the ischemic injury. Consisting of the ACTH

Indexed as

Adrenocorticotropic HormoneAnimalsAntigen PresentationBrain IschemiaDisease Models, AnimalGene Expression ProfilingGenes, Immunoglobulin Heavy ChainImmunoglobulin Heavy ChainsMaleMiddle Cerebral ArteryNeuroprotective AgentsOligopeptidesPeptide FragmentsProlineRatsRats, WistarACTH (4-7), Pro-Gly-Pro-Adrenocorticotropic HormoneImmunoglobulin Heavy ChainsNeuroprotective AgentsOligopeptidesPeptide FragmentsProlineprolyl-glycyl-prolineACTH analogCerebral ischemia modelGenome-wide transcriptome analysisImmune responseNeuroprotective regulatory peptidesPro-Gly-ProSemax

Identifiers

PMID28255762
OpenAlexW2594819773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.